BSEM insider trading
NasdaqCM HealthcareBioStem Technologies, Inc.: insider trade history from SEC Form 4 filings.
About BioStem Technologies, Inc.
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Company website: biostemtechnologies.com
BSEM insider activity at a glance
FilingIQ tracks 15 insider transactions for BSEM in filings since Aug 20, 2026. The most recent transaction is dated Sep 17, 2026.
Across the full history, 0 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
Latest BSEM Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BSEM?
- FilingIQ tracks 15 Form 4 insider transactions for BSEM (BioStem Technologies, Inc.), covering filings from Aug 20, 2026 onwards. 15 of those are dated within the last 90 days.
- Are BSEM insiders net buyers or net sellers?
- Across the full Form 4 history for BSEM, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BSEM insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is BSEM in?
- BioStem Technologies, Inc. (BSEM) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $69.59M.
Methodology & sources
Every BSEM insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.